N

New York Medical College | Boston Children's Hospital - Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine

Research site

(Unclaimed)

Location

19 Bradhurst Avenue Suite 1400-South, Hawthorne, New York, United States of America

Site insights

Top conditions

Top treatments

Cytarabine

Dociparstat

VX-440

R-CHOP

Lorcaserin

Inotuzumab

Gemcitabine

Sodium Fusidate

Ozogamicin

VX-828

Parent organization

This site is a part of New York Medical College

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 25 total trials

A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

CMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of...

Active, not recruiting

Persistent Infection

Cystic Fibrosis

Drug: Placebo

Drug: CMTX-101

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 and VX-828 in triple combination (TC) with Tezacaftor (T...

Enrolling

Cystic Fibrosis

Drug: Tezacaftor

Drug: VX-828

Status recently updated

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta (PreciSION CF)

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF wh...

Begins enrollment this month

Enrolling

Cystic Fibrosis (CF)

Drug: SION-719

Drug: Placebo-to-match SION-719